Drugs / Sendai virus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00186927 | May 2005 → Jan 2027 | parainfluenza virus type 1 infectious disease, viral respiratory tract infection | St. Jude Children's Research Hospital | Suspended | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sendai virus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00186927 ↗ |
| Known as | SeV | “Sendai virus (SeV) is a murine PIV-1.” PMID 40333329 ↗ Apr 2025 |
| Modality | Vaccine | “This research study is testing a new experimental live-virus vaccine that is given by placing liquid drops in the nose.” NCT00186927 ↗ |
| Route | Intranasal | “a live, unmodified intranasally administered Sendai virus vaccine” NCT00186927 ↗ |